Top 5 Stocks to Buy Now
→ Elon just crossed $1 trillion. Who's next? (From Chaikin Analytics) (Ad)tc pixel Free RAMP Stock Alerts

LiveRamp (RAMP) Competitors

LiveRamp logo
$37.62 +0.01 (+0.03%)
As of 06/23/2026 03:58 PM Eastern
Compare

RAMP vs. QBTS, STN, BILI, HQY, and ZG

Should you buy LiveRamp stock or one of its competitors? MarketBeat compares LiveRamp with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with LiveRamp include D-Wave Quantum (QBTS), Stantec (STN), Bilibili (BILI), HealthEquity (HQY), and Zillow Group (ZG). These companies are all part of the "business services" industry.

How does LiveRamp compare to D-Wave Quantum?

D-Wave Quantum (NYSE:QBTS) and LiveRamp (NYSE:RAMP) are both mid-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends.

42.5% of D-Wave Quantum shares are owned by institutional investors. Comparatively, 93.8% of LiveRamp shares are owned by institutional investors. 1.3% of D-Wave Quantum shares are owned by insiders. Comparatively, 3.3% of LiveRamp shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

LiveRamp has higher revenue and earnings than D-Wave Quantum. D-Wave Quantum is trading at a lower price-to-earnings ratio than LiveRamp, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
D-Wave Quantum$24.59M376.38-$355.06M-$1.13N/A
LiveRamp$812.94M2.78$145.95M$2.2816.50

In the previous week, D-Wave Quantum had 25 more articles in the media than LiveRamp. MarketBeat recorded 28 mentions for D-Wave Quantum and 3 mentions for LiveRamp. D-Wave Quantum's average media sentiment score of 0.62 beat LiveRamp's score of 0.23 indicating that D-Wave Quantum is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
D-Wave Quantum
14 Very Positive mention(s)
7 Positive mention(s)
3 Neutral mention(s)
4 Negative mention(s)
0 Very Negative mention(s)
Positive
LiveRamp
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

LiveRamp has a net margin of 17.95% compared to D-Wave Quantum's net margin of -2,957.23%. LiveRamp's return on equity of 8.28% beat D-Wave Quantum's return on equity.

Company Net Margins Return on Equity Return on Assets
D-Wave Quantum-2,957.23% -44.06% -38.48%
LiveRamp 17.95%8.28%6.29%

D-Wave Quantum presently has a consensus target price of $36.80, indicating a potential upside of 47.08%. LiveRamp has a consensus target price of $40.21, indicating a potential upside of 6.90%. Given D-Wave Quantum's stronger consensus rating and higher possible upside, equities research analysts plainly believe D-Wave Quantum is more favorable than LiveRamp.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
D-Wave Quantum
1 Sell rating(s)
2 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.76
LiveRamp
0 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

D-Wave Quantum has a beta of 2.05, indicating that its share price is 105% more volatile than the broader market. Comparatively, LiveRamp has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market.

Summary

LiveRamp beats D-Wave Quantum on 9 of the 16 factors compared between the two stocks.

How does LiveRamp compare to Stantec?

LiveRamp (NYSE:RAMP) and Stantec (NYSE:STN) are both mid-cap business services companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, dividends, profitability, earnings, risk, analyst recommendations, media sentiment and institutional ownership.

In the previous week, Stantec had 1 more articles in the media than LiveRamp. MarketBeat recorded 4 mentions for Stantec and 3 mentions for LiveRamp. LiveRamp's average media sentiment score of 0.23 beat Stantec's score of 0.21 indicating that LiveRamp is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LiveRamp
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Stantec
0 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

LiveRamp currently has a consensus target price of $40.21, suggesting a potential upside of 6.90%. Stantec has a consensus target price of $175.00, suggesting a potential upside of 156.82%. Given Stantec's stronger consensus rating and higher probable upside, analysts clearly believe Stantec is more favorable than LiveRamp.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LiveRamp
0 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Stantec
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

Stantec has higher revenue and earnings than LiveRamp. LiveRamp is trading at a lower price-to-earnings ratio than Stantec, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LiveRamp$812.94M2.78$145.95M$2.2816.50
Stantec$5.83B1.33$343.11M$3.1221.84

LiveRamp has a net margin of 17.95% compared to Stantec's net margin of 5.92%. Stantec's return on equity of 19.37% beat LiveRamp's return on equity.

Company Net Margins Return on Equity Return on Assets
LiveRamp17.95% 8.28% 6.29%
Stantec 5.92%19.37%8.03%

LiveRamp has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market. Comparatively, Stantec has a beta of 0.98, meaning that its share price is 2% less volatile than the broader market.

93.8% of LiveRamp shares are held by institutional investors. Comparatively, 63.9% of Stantec shares are held by institutional investors. 3.3% of LiveRamp shares are held by insiders. Comparatively, 0.5% of Stantec shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Stantec beats LiveRamp on 10 of the 16 factors compared between the two stocks.

How does LiveRamp compare to Bilibili?

LiveRamp (NYSE:RAMP) and Bilibili (NASDAQ:BILI) are both mid-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, valuation, media sentiment, risk, earnings, analyst recommendations, dividends and institutional ownership.

LiveRamp presently has a consensus price target of $40.21, indicating a potential upside of 6.90%. Bilibili has a consensus price target of $30.78, indicating a potential upside of 92.84%. Given Bilibili's stronger consensus rating and higher possible upside, analysts clearly believe Bilibili is more favorable than LiveRamp.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LiveRamp
0 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Bilibili
1 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.80

Bilibili has higher revenue and earnings than LiveRamp. LiveRamp is trading at a lower price-to-earnings ratio than Bilibili, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LiveRamp$812.94M2.78$145.95M$2.2816.50
Bilibili$4.34B1.53$170.67M$0.4535.47

In the previous week, Bilibili had 6 more articles in the media than LiveRamp. MarketBeat recorded 9 mentions for Bilibili and 3 mentions for LiveRamp. LiveRamp's average media sentiment score of 0.23 beat Bilibili's score of -0.69 indicating that LiveRamp is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LiveRamp
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Bilibili
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
4 Very Negative mention(s)
Negative

93.8% of LiveRamp shares are held by institutional investors. Comparatively, 16.1% of Bilibili shares are held by institutional investors. 3.3% of LiveRamp shares are held by company insiders. Comparatively, 22.2% of Bilibili shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

LiveRamp has a net margin of 17.95% compared to Bilibili's net margin of 4.58%. Bilibili's return on equity of 10.81% beat LiveRamp's return on equity.

Company Net Margins Return on Equity Return on Assets
LiveRamp17.95% 8.28% 6.29%
Bilibili 4.58%10.81%4.04%

LiveRamp has a beta of 1.27, meaning that its stock price is 27% more volatile than the broader market. Comparatively, Bilibili has a beta of 0.71, meaning that its stock price is 29% less volatile than the broader market.

Summary

Bilibili beats LiveRamp on 9 of the 16 factors compared between the two stocks.

How does LiveRamp compare to HealthEquity?

LiveRamp (NYSE:RAMP) and HealthEquity (NASDAQ:HQY) are both mid-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, dividends, media sentiment, analyst recommendations, institutional ownership, earnings, risk and profitability.

In the previous week, HealthEquity had 2 more articles in the media than LiveRamp. MarketBeat recorded 5 mentions for HealthEquity and 3 mentions for LiveRamp. HealthEquity's average media sentiment score of 1.60 beat LiveRamp's score of 0.23 indicating that HealthEquity is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LiveRamp
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
HealthEquity
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

93.8% of LiveRamp shares are owned by institutional investors. Comparatively, 99.6% of HealthEquity shares are owned by institutional investors. 3.3% of LiveRamp shares are owned by insiders. Comparatively, 1.6% of HealthEquity shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

LiveRamp presently has a consensus price target of $40.21, suggesting a potential upside of 6.90%. HealthEquity has a consensus price target of $110.57, suggesting a potential upside of 30.21%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts clearly believe HealthEquity is more favorable than LiveRamp.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LiveRamp
0 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
HealthEquity
1 Sell rating(s)
1 Hold rating(s)
11 Buy rating(s)
1 Strong Buy rating(s)
2.86

LiveRamp has a net margin of 17.95% compared to HealthEquity's net margin of 17.25%. HealthEquity's return on equity of 14.75% beat LiveRamp's return on equity.

Company Net Margins Return on Equity Return on Assets
LiveRamp17.95% 8.28% 6.29%
HealthEquity 17.25%14.75%9.22%

LiveRamp has a beta of 1.27, suggesting that its share price is 27% more volatile than the broader market. Comparatively, HealthEquity has a beta of 0.21, suggesting that its share price is 79% less volatile than the broader market.

HealthEquity has higher revenue and earnings than LiveRamp. LiveRamp is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LiveRamp$812.94M2.78$145.95M$2.2816.50
HealthEquity$1.31B5.41$215.20M$2.6731.81

Summary

HealthEquity beats LiveRamp on 14 of the 17 factors compared between the two stocks.

How does LiveRamp compare to Zillow Group?

LiveRamp (NYSE:RAMP) and Zillow Group (NASDAQ:ZG) are both mid-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

LiveRamp presently has a consensus target price of $40.21, suggesting a potential upside of 6.90%. Zillow Group has a consensus target price of $69.43, suggesting a potential upside of 127.19%. Given Zillow Group's stronger consensus rating and higher probable upside, analysts clearly believe Zillow Group is more favorable than LiveRamp.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LiveRamp
0 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25
Zillow Group
1 Sell rating(s)
12 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.46

LiveRamp has a net margin of 17.95% compared to Zillow Group's net margin of 2.27%. LiveRamp's return on equity of 8.28% beat Zillow Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LiveRamp17.95% 8.28% 6.29%
Zillow Group 2.27%1.41%1.22%

LiveRamp has a beta of 1.27, indicating that its share price is 27% more volatile than the broader market. Comparatively, Zillow Group has a beta of 1.94, indicating that its share price is 94% more volatile than the broader market.

93.8% of LiveRamp shares are held by institutional investors. Comparatively, 20.3% of Zillow Group shares are held by institutional investors. 3.3% of LiveRamp shares are held by company insiders. Comparatively, 29.9% of Zillow Group shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

LiveRamp has higher earnings, but lower revenue than Zillow Group. LiveRamp is trading at a lower price-to-earnings ratio than Zillow Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LiveRamp$812.94M2.78$145.95M$2.2816.50
Zillow Group$2.58B2.71$23M$0.25122.24

In the previous week, Zillow Group had 11 more articles in the media than LiveRamp. MarketBeat recorded 14 mentions for Zillow Group and 3 mentions for LiveRamp. LiveRamp's average media sentiment score of 0.23 beat Zillow Group's score of 0.19 indicating that LiveRamp is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LiveRamp
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Zillow Group
2 Very Positive mention(s)
0 Positive mention(s)
12 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

LiveRamp and Zillow Group tied by winning 8 of the 16 factors compared between the two stocks.

Get LiveRamp News Delivered to You Automatically

Sign up to receive the latest news and ratings for RAMP and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RAMP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RAMP vs. The Competition

Export
MetricLiveRampTechnology Services IndustryBusiness SectorNYSE Exchange
Market Cap$2.26B$4.40B$6.74B$23.26B
Dividend YieldN/A2.13%3.23%4.07%
P/E Ratio16.5040.8527.6731.08
Price / Sales2.7845.54394.2721.83
Price / Cash30.3638.2823.2024.45
Price / Book2.444.565.684.64
Net Income$145.95M$31.97M$205.77M$1.07B
7 Day Performance-0.08%-1.47%5.48%0.15%
1 Month Performance-0.22%-4.00%-0.39%0.18%
1 Year Performance14.15%22.12%29.33%23.21%

LiveRamp Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RAMP
LiveRamp
2.7151 of 5 stars		$37.62
+0.0%		$40.21
+6.9%		+20.0%$2.26B$812.94M16.501,300
QBTS
D-Wave Quantum
3.5141 of 5 stars		$26.29
+12.5%		$36.80
+40.0%		+67.7%$8.64B$24.59MN/A3
STN
Stantec
4.6867 of 5 stars		$71.17
-1.5%		$175.00
+145.9%		-36.1%$8.24B$5.83B22.8134,000
BILI
Bilibili
4.0263 of 5 stars		$17.85
-0.1%		$30.78
+72.4%		-19.8%$7.41B$4.34B39.678,423
HQY
HealthEquity
4.8657 of 5 stars		$86.97
-1.6%		$110.57
+27.1%		-16.1%$7.39B$1.31B32.572,814

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NYSE:RAMP) was last updated on 6/24/2026 by MarketBeat.com Staff.
From Our Partners
My feud with Zohran Mamdani
Nearly 40% of Americans now hold a positive view of socialism - and former hedge fund manager Whitney Tilson s...
Stansberry Research | Sponsoredtc pixel
Quick favor to ask you
Bill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...
Profits Run | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Top Banks Warn: A Strange Day is Coming to America
Goldman Sachs and Morgan Stanley are warning clients about a developing crisis that could suppress portfolio g...
TradeSmith | Sponsoredtc pixel
A drilling crew just broke a record nobody expected
A drilling crew in Beaver County, Utah hit 15,765 feet of solid granite in 16 days - a job the Department of E...
Behind the Markets | Sponsoredtc pixel
Read this before you touch SPCX
SPCX is live on Nasdaq - but a market expert who called AMD before it climbed as high as 7,100% says buying th...
Altimetry | Sponsoredtc pixel
Millionaire trader who went 13-for-13 on Trump in 2025 now turns his attention to Elon.
Hedge fund trader Larry Benedict went 13-for-13 in Q1 2025 - not a single losing trade - and finished the year...
Brownstone Research | Sponsoredtc pixel
Karp just filed Form 144
On May 12, 2026, Palantir CEO Alex Karp filed to sell 585,000 shares - roughly $95.93 million. Combined with f...
Porter & Company | Sponsoredtc pixel